Leaps by Bayer
Corporate VCLeverkusen · Seed–Growth · 7 people tracked
Team · 7 people
from public directories
What they invest in
from 8 of 8 portfolio companiesBiotech ×6AI & Machine Learning ×4Deep Tech ×3Digital Health ×2FoodTech ×2Medical Devices ×2AgTech ×1Fintech ×1
HQs:United States×5
Investments · 8 tracked
founders shown can be your intro pathBy year:2021 · 12019 · 23 dated
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Mark Murcko, Ph.D.(Director)Richard Young, Ph.D.(Director)Elisabeth Leiderman(Executive Officer)Ameet Nathwani, M.D.(Executive Officer, Director)Isaac Klein, M.D., Ph.D.(Executive Officer)Lori Escobedo(Executive Officer)
Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease.
AI & Machine LearningBiotechDeep Tech
Victor Kotelianski(Founder)Daniel Anderson(Founder)Robert Langer(Founder)Marino Zerial(Founder)Brad Pentelute(Founder)Amir Nashat(Chief Executive Officer)
Apollo Agriculture provides financing, farm inputs, insurance, and agricultural training to smallholder farmers, using machine learning credit models to make instant lending decisions.
AgTechAI & Machine LearningFintechOakland, US
Earl Joseph St. Sauver(Director)Seth Todd Silverman(Director)Eli John Pollak(Executive Officer, Director)Eli Pollak(Co-founder & CEO)Benjamin Njenga(Co-founder)Earl St Sauver(Co-founder)
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale.
BiotechDeep TechFoodTechNutley, US
Gabor Forgacs(Chief Scientific Officer and co-founder)Andras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)Niyati Gupta(Executive Officer, Director)Lauren Loktev(Director)
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)Juergen Eckhardt(Director)
BoardLaura Brass(Director)
NextPoint is developing precision cancer therapeutics based on the B7-H7/HHLA2 axis, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors for cancer patients.
BiotechDigital HealthMedical DevicesAustin, US
Ivan Cheung(Executive Officer, Director)Axel Hoos(Director)Jeffrey Lacey(Executive Officer)
BoardDetlev Biniszkiewicz(Director)R. Jacob Vogelstein(Director)Brian Shuster(Director)
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)
Portfolio news
latest coverage across their companiesNextPoint Therapeutics · nature.com · Jul 22, 2026
Nava · endpoints.news · Jul 15, 2026
Fork & Good · greenqueen.com.hk · Feb 18, 2025
Frequently asked questions
- What stage does Leaps by Bayer invest at?
- Leaps by Bayer invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Leaps by Bayer focus on?
- Leaps by Bayer focuses on AgTech, Biotech, Healthtech.
- Where is Leaps by Bayer located?
- Leaps by Bayer is headquartered in Leverkusen, DE.
Co-investors · 16
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Agent Capital is a healthcare venture capital firm that invests in novel, differentiated therapeutics and treatments addressing unmet patient needs across all stages of development.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.
Founder Collective is an early-stage venture capital firm focused on seed and pre-seed investments across all sectors.
Lux Capital's portfolio page showcasing select companies across science and technology sectors including AI infrastructure, aerospace, biotech, and productivity software.
IA Ventures is a venture capital firm that invests in early-stage software and frontier technology companies.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Paladin Capital Group is a global investment firm backing innovative companies in cybersecurity, secure AI, and deep tech.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
The Column Group (TCG) is a venture capital firm focused on building and backing biotechnology companies, applying an edge-to-edge investment model centered on company formation with capacity for long-term private and public capital support.
▶4 more co-investors
Cofounders CapitalInnova Memphis, Inc.Lever VCFulcrum Global Capital
Firms observed investing alongside Leaps by Bayer, from public investor directories. Shared companies are the overlap with Leaps by Bayer's recorded portfolio.
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.
Rho is an investment firm founded in 1981 that backs inventors, entrepreneurs, and operators across all stages of company growth to build market-defining companies.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.